UI Healthcare LogoInternal Medicine Home Pagespacer imageEducation InformationPatient Care InformationResearch Informationspacer imageDivisions of the DepartmentFaculty
Diversity and Culture ConferencesNews and EventsGiving Opportunitiesspacer imageServicesIntranet (login required)Useful LinksContact Usspacer imageThe University of Iowa

 

UI Healthcare Navigation Bar UI Healthcare Home Page About Us Appointments Contact UI Healthcare Staff Departments Health Topics Search

Department of Internal Medicine

Hematology, Oncology and Blood & 
Marrow Transplantation Faculty


Gerald H. Clamon, M.D.
Professor

Dr. Clamon's clinical and research interests focus on studies of experimental therapeutics for advanced cancer. His clinical care is directed at the treatment, palliation, and support of patients with advanced cancer.

Honors, Awards, and Organizations

  • Phi Beta Kappa
  • Alpha Omega Alpha
  • American Association for Cancer Research
  • Diplomate, American Board of Internal Medicine and Board of Medical Oncology, and Board of Hematology
  • American Society of Clinical Oncology
  • International Association for the Study of Lung Cancer
  • Principle Investigator, UI Membership in CALGB
  • Reviewer, Chest, 1982-present
  • Reviewer, Cancer, 1998-present
  • Reviewer, Journal of Clinical Oncology, 1999-present
  • Membership Committee, CALGB, 1986-present
  • DATA Audit Committee, CALGB, 1992-97
  • Chair, Clinical Cancer Center Protocol Review Committee, 1996-97

Gerald Clamon photo

Medical School:
Washington University

Residency:
Washington University

Fellowship:
The University of Iowa

Special Training:
Research, National Cancer Institute

Recent Publications

  1. Rocha Lima, C.M.S., Herndon II, J.E., Kosty, M., Clamon, G., Green, M.R.:  Therapy Choices Among Older Patients with Lung Cancer: An Evaluation of Two Trials of the Cancer and Leukemia Group B. Cancer  94(Volume 1): 181-187, 2002.
  2. Niell, H.B, Perry, M.C., Clamon, G., Crawford, J., Miller, A.A., Herndon II, J., and Green, M.R.  Carboplatin/Etoposide/Paclitaxel in the Treatment of Patients with Extensive Small-Cell Lung Cancer.  Clinical Lung Cancer,
    2 (No 3):204-209, 2001.
  3. Clamon, G., Herndon, J., Green, M., and Akerley, W.:  Subcutaneous Interleukin-2 as Initial Therapy for Patients with Extensive Small Cell Lung Cancer.  A Phase II Trial of Cancer and Leukemia Group B.  Lung Cancer, 19 :25-29, 1998.

Back to Hematology-Oncology Faculty List

 


UI Healthcare Home | About Us | Appointments | Contact UI Healthcare | Departments | Health Library | Search

Home | Education | Patient Care | Research
Divisions | Faculty | Conferences | News & Events | Giving Opportunities
Services | Intranet | Useful Links | Contact Us